Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 22, 2002
Thalidomide in myelodysplastic syndromesF Zorat, G Pozzato
Clinical and Experimental Rheumatology|March 15, 2002
Effectiveness of leukocyte interferon in patients affected by HCV-positive mixed cryoglobulinemia resistant to recombinant alpha-interferonC Mazzaro, R Colle, S Baracetti, et al.
Anticancer Research|March 4, 2000
Measurement of mRNA expression for a variety of cytokines and its receptors in bone marrows of patients with myelodysplastic syndromesK Allampallam, V Shetty, S Hussaini, et al.
British Journal of Haematology|August 25, 1999
GBV-C/HGV and HCV infection in mixed cryoglobulinaemiaM Crovatto, C Mazzaro, S Mishiro, et al.
Italian Journal of Gastroenterology and Hepatology|December 22, 1999
Recovery from hepatitis C virus-positive cryoglobulinaemic glomerulonephritis after interferon therapyC Mazzaro, A Faelli, S Baracetti, et al.
Italian Journal of Gastroenterology and Hepatology|August 1, 1997
Pilot study on the safety and efficacy of intravenous natural beta-interferon therapy in patients with chronic hepatitis C unresponsive to alpha-interferonL Mazzoran, G Grassi, M Giacca, et al.
European Journal of Gastroenterology & Hepatology|May 15, 1998
Effects of interferon therapy on fibrosis serum markers in HCV-positive chronic liver diseaseL Mazzoran, G Tamaro, M A Mangiarotti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 4, 2001
Human leucocyte interferon-alpha in the treatment of chronic hepatitis CL Mazzoran, F Zorat, L Chemello, et al.
Blood|August 15, 2000
Intramedullary apoptosis of hematopoietic cells in myelodysplastic syndrome patients can be massive: apoptotic cells recovered from high-density fraction of bone marrow aspiratesV Shetty, S Hussaini, L Broady-Robinson, et al.
British Journal of Haematology|February 15, 2002
The clinical and biological effects of thalidomide in patients with myelodysplastic syndromesF Zorat, V Shetty, D Dutt, et al.
Pageof 2